News

Activation Capital $15,000 Pitch Contest in November to Shine Light on Virginia Businesses

The inaugural Pitch Virginia event, powered by Activation Capital, will take place on Wednesday, November 10 at the newly opened Shift Retail Lab at VCU, an initiative of the VCU da Vinci Center.  Kicking off with a design thinking workshop in the morning, the day will be filled with pitches from high growth, main street and student companies competing for $15,000 of prize money, concluding with the grand opening event of the Shift Retail Lab at VCU with a cocktail networking event and open house tours of the space in the evening.  These events are an official activity of Global Entrepreneurship Week, an international movement to empower entrepreneurs and help make it possible for anyone, anywhere to start and scale.

Pitch Virginia is an opportunity to highlight the entrepreneurs and startup companies in the Commonwealth.  The contest will feature three categories: high growth startups, main street companies, and student-owned ventures.  Capital One is sponsoring the event and donated $15,000 in cash prizes for winning companies.

Matt Briggs, VP of Capital One Card Technology and Platforms shared, “Capital One is committed to elevating the mission driven small business ecosystem in Virginia and our support for this event allows us to empower entrepreneurs at all levels – student entrepreneurs, brick and mortar businesses, and high growth startups with the potential to scale. We are looking forward to November and Pitch Virginia to bring innovative minds and ecosystem supporters together to continue developing Virginia’s small business sector.”

Speaking about Pitch Virginia, Chandra Briggman, President and CEO of Activation Capital said, “We wanted to create a new event that will cater to founders and entrepreneurs, showcasing all types of companies, and feel Pitch Virginia will be a place for people to come together for networking and community, while also supporting the entrepreneurial ecosystem in the Commonwealth.”

Companies can apply to pitch and individuals can register to attend at http://activation.capital/pitch.

Recent News

10/20/2026

Supernus Reaches Key Milestone Toward Proposed Merger with Indivior Following Shareholder Approval

Supernus Pharmaceuticals, Inc. welcomed the decisive backing of shareholders today, who formally voted to approve the pending all-stock merger of equals. This vote marks an important milestone toward completing the merger announced in August 2026, with closing anticipated on November 2, 2026, subject to customary closing conditions. Following closing, the combined organization will officially commence …

10/20/2026

GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced 27 accepted scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, highlighting how exome and genome sequencing are advancing scientific discovery, earlier diagnosis and more precise care. GeneDx research at ASHG 2026 highlights …

10/16/2026

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”), which recently acquired Azora Therapeutics, today announced the appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist. Dr. Rubenstein will lead the Company’s research and scientific strategy, including the continued development of AT177, a proprietary, oral, colon-targeted aryl hydrocarbon receptor (AhR) agonist being developed for the …